These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


120 related items for PubMed ID: 29108652

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sodium oxybate-induced psychosis and suicide attempt in an 18-year-old girl.
    Chien J, Ostermann G, Turkel SB.
    J Child Adolesc Psychopharmacol; 2013 May; 23(4):300-1. PubMed ID: 23647134
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sodium oxybate is an effective and safe treatment for narcolepsy.
    Lammers GJ, Bassetti C, Billiard M, Black J, Broughton R, Dauvilliers Y, Ferini Strambi L, Garcia-Borreguero D, Goswami M, Högl B, Iranzo A, Jennum P, Khatami R, Lecendreux M, Mayer G, Mignot E, Montplaisir J, Nevsimalova S, Peraita-Adrados R, Plazzi G, Scammell T, Silber M, Sonka K, Tafti M, Thorpy M.
    Sleep Med; 2010 Jan; 11(1):105-6; author reply 106-8. PubMed ID: 19846338
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J, Pardi D, Hornfeldt CS, Inhaber N.
    Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
    [Abstract] [Full Text] [Related]

  • 8. Xyrem (sodium oxybate) postmarketing adverse event reporting system.
    Wang YG.
    Sleep Med; 2010 Jun; 11(6):595; author reply 595-6. PubMed ID: 20362501
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sodium oxybate: efficacy, safety and tolerability in the treatment of narcolepsy with or without cataplexy.
    Owen RT.
    Drugs Today (Barc); 2008 Mar; 44(3):197-204. PubMed ID: 18536781
    [Abstract] [Full Text] [Related]

  • 13. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study.
    Mansukhani MP, Kotagal S.
    Sleep Med; 2012 Jun; 13(6):606-10. PubMed ID: 22445591
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term follow-up of patients with narcolepsy-cataplexy treated with sodium oxybate (Xyrem).
    Alshaikh MK, Gacuan D, George S, Sharif M, Bahammam AS.
    Clin Neuropharmacol; 2011 Jun; 34(1):1-4. PubMed ID: 21206362
    [Abstract] [Full Text] [Related]

  • 19. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.
    Prescrire Int; 2007 Jun; 16(89):98-101. PubMed ID: 17582923
    [Abstract] [Full Text] [Related]

  • 20. Sodium oxybate and breathing.
    Ortega-Albas JJ, López-Bernabé R, Diaz JR, Serrano AL.
    Sleep Breath; 2010 Sep; 14(3):259. PubMed ID: 19941084
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.